Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H18O7 |
Molecular Weight | 358.342 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C(=O)C(OC)=C(O2)C3=CC(OC)=C(OC)C=C3)C(O)=C1
InChI
InChIKey=HHGPYJLEJGNWJA-UHFFFAOYSA-N
InChI=1S/C19H18O7/c1-22-11-8-12(20)16-15(9-11)26-18(19(25-4)17(16)21)10-5-6-13(23-2)14(7-10)24-3/h5-9,20H,1-4H3
Retusin is an O-methylated isoflavone, a type of flavonoid. It can be found in Fabaceae species like Dipteryx odorata, in Dalbergia retusa and in Millettia nitida. Retusin exhibited potent free-radical-scavenging capacity as well as efficient inhibition of cellular melanogenesis, suggesting that it is a valuable hit compound with potential for advanced cosmeceutical development. Retusin showed efficient inhibition both of cellular melanin formation and anti-tyrosinase activity in B16F10 melanocytes. Retusin exhibited an anti-emetic effect in chick model.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3318 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26080742 |
50.9 µM [IC50] | ||
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26080742 |
|||
Target ID: CHEMBL5393 |
390.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Effect of different flavonoids on collagen synthesis in human fibroblasts. | 2006 Mar |
|
Anti-allergic activity of compounds from Kaempferia parviflora. | 2008 Feb 28 |
|
Inhibitory effects of quercetin derivatives on phosphodiesterase isozymes and high-affinity [(3) H]-rolipram binding in guinea pig tissues. | 2008 Oct |
|
Effects of compounds from Kaempferia parviflora on nitric oxide, prostaglandin E2 and tumor necrosis factor-alpha productions in RAW264.7 macrophage cells. | 2008 Oct 30 |
|
Anti-inflammatory mechanism of Kaempferia parviflora in murine macrophage cells (RAW 264.7) and in experimental animals. | 2009 Jul 30 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374246
Retusin inhibited emetic action of copper sulfate at two doses of 20 mg/kg and
50 mg/kg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26080742
Retusin inhibited mushroom tyrosinase activity with the IC50 value of 50.9 uM at 30 min.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
61837
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
M8591903SD
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
214-991-4
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
1245-15-4
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
5352005
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
144096
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
618937
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
Retusin (flavonol)
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
DTXSID60924839
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
144861
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD